Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

128
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
128
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

153
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
153
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

324
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
324
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
118
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multi-region sampling of the human small intestine using an ingestible device.

medRxiv : the preprint server for health sciences·2026
Same author

Current burden and health care utilization of inflammatory bowel disease in the United States, 2023-2024.

Intestinal research·2026
Same author

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Jointly-hic: joint decomposition of contact frequency maps captures salient features of genome architecture across tissues and development.

Genome biology·2026
Same author

Statin use is associated with lower rates of stricture development in patients with Crohn's disease: a propensity score-matched study of two nationwide population databases.

Journal of Crohn's & colitis·2026
Same author

Multi-omics reveal vitamin D regulation of immune-gut microbiome interactions and tolerogenic pathways in inflammatory bowel disease.

Cell reports. Medicine·2026
Same journal

Comment on: Continuous versus intermittent anticoagulation during endoscopic treatment of esophageal varices in cirrhosis: a randomized controlled trial.

Therapeutic advances in gastroenterology·2026
Same journal

Upadacitinib for anti-TNFα refractory immune checkpoint inhibitor-induced colitis: a case report.

Therapeutic advances in gastroenterology·2026
Same journal

International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease.

Therapeutic advances in gastroenterology·2026
Same journal

Age-stratified colonoscopy outcomes and referral-factor associations in the Swedish colorectal cancer fast-track pathway: a retrospective cohort study.

Therapeutic advances in gastroenterology·2026
Same journal

The role of enteroscopy in the diagnosis and interventional management of small intestine diseases.

Therapeutic advances in gastroenterology·2026
Same journal

Impact of wet suction on specimen quality and diagnostic accuracy in EUS-guided tissue acquisition: a systematic review and meta-analysis of randomized controlled trials.

Therapeutic advances in gastroenterology·2026
查看所有相关文章

相关实验视频

Updated: Jun 13, 2025

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.0K

人工智能和机器学习技术在性结肠炎中的应用

Chiraag Kulkarni1, Derek Liu1, Touran Fardeen1

  • 1Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA.

Therapeutic advances in gastroenterology
|September 9, 2024
PubMed
概括
此摘要是机器生成的。

人工智能 (AI) 和机器学习 (ML) 在改善性结肠炎 (UC) 护理方面表现有前途,有助于诊断,预后和并发症预测. 临床整合需要进一步验证.

关键词:
人工智能是一种人工智能.生物标志物 生物标志物机器学习是机器学习.结果就是结果.预测 预测 预测 预测性结肠炎是一种

更多相关视频

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

8.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

相关实验视频

Last Updated: Jun 13, 2025

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.0K
Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

8.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

科学领域:

  • 胃肠病学 胃肠病学
  • 医疗信息学 医疗信息学
  • 计算生物学 计算生物学

背景情况:

  • 人工智能 (AI) 对治疗性结肠炎 (UC) 的兴趣日益增长.
  • 在过去的5年里,有80多项研究探讨了UC临床问题的机器学习 (ML).

研究的目的:

  • 审查AI和ML在性结肠炎 (UC) 的应用.
  • 突出AI/ML在UC诊断,预后,生物标志物识别,疾病监测和并发症预测中的使用.

主要方法:

  • 在分子和临床数据上利用AI分类器 (例如随机森林,支持矢量机器,神经网络).
  • 应用ML算法 (例如计算机视觉,卷积神经网络) 来分析成像数据 (内镜,组织学,放射学).

主要成果:

  • 在建模UC结果时,AI/ML模型表现出高性能 (精度,灵敏度,特异性).
  • 机器学习算法成功分析了复杂的成像数据集,用于UC诊断和并发症预测.

结论:

  • 人工智能和机器学习工具为优化性结肠炎 (UC) 临床实践提供了一个有希望的方法.
  • 大规模,高质量的验证研究对于减轻偏见和评估临床整合的成本效益至关重要.